The ADHAPT technology

A protein based bio-adhesive tablet for mucosal administration. ADHAPT® is based on a technology that allies a low cost process with patient compliance.

The ADHAPT® patent is held by APTYS Pharmaceuticals. Licences were granted to Bioalliance Pharma.